Cite
Ostrowitzki S, Lasser RA, Dorflinger E, et al. Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease. Alzheimers Res Ther. 2018;10(1):99doi: 10.1186/s13195-018-0409-4.
Ostrowitzki, S., Lasser, R. A., Dorflinger, E., Scheltens, P., Barkhof, F., Nikolcheva, T., Ashford, E., Retout, S., Hofmann, C., Delmar, P., Klein, G., Andjelkovic, M., Dubois, B., Boada, M., Blennow, K., Santarelli, L., Fontoura, P. (2018). Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease. Alzheimer's research & therapy, 10(1), 99. https://doi.org/10.1186/s13195-018-0409-4
Ostrowitzki, Susanne, et al. "Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease." Alzheimer's research & therapy vol. 10,1 (2018): 99. doi: https://doi.org/10.1186/s13195-018-0409-4
Ostrowitzki S, Lasser RA, Dorflinger E, Scheltens P, Barkhof F, Nikolcheva T, Ashford E, Retout S, Hofmann C, Delmar P, Klein G, Andjelkovic M, Dubois B, Boada M, Blennow K, Santarelli L, Fontoura P. Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease. Alzheimers Res Ther. 2018 Sep 27;10(1):99. doi: 10.1186/s13195-018-0409-4. PMID: 30261916; PMCID: PMC6158837.
Copy
Download .nbib